Clinical Trials for Alebund Pharmaceuticals

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Alebund Pharmaceuticals

Clinical Trials (3)

NCT06933472
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
PHASE3Recruiting
264 participants
Started: Jun 13, 2025 · Completed: Jan 10, 2027
4 conditions2 sponsors31 locations
NCT06712654
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 At Fixed Doses in Patients with Hyperphosphatemia
PHASE2Not yet recruiting
144 participants
Started: Apr 10, 2025 · Completed: Dec 30, 2025
2 conditions1 sponsor0 locations
NCT06666283
A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients
PHASE1Recruiting
18 participants
Started: Feb 27, 2025 · Completed: Sep 25, 2025
1 condition1 sponsor1 location